Fingerprint
Dive into the research topics of 'Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically